Intrinsic Clinical Systems, a clinical development services and technology platform, announces that it has acquired BioPhy, an enterprise AI company focused on regulatory intelligence and quality system modernization for life sciences organizations. BioPhy’s solutions help regulatory, quality, and operations teams navigate complex requirements and documentation at speed. In addition, BioPhy offers a QMS gap analysis solution that helps organizations assess alignment between current SOPs, quality documentation, and applicable requirements.
Read the full article: BioPhy Acquired by Intrinsic Clinical Systems //
Source: https://www.einpresswire.com/article/888678136/biophy-acquired-by-intrinsic-clinical-systems